Charles McDermott

President, Director & Chief Business Officer at Impact Biomedicines, Inc.

Charles McDermott

Charles McDermott

President, Director & Chief Business Officer at Impact Biomedicines, Inc.

Overview
Career Highlights

Kala Pharmaceuticals, Inc.

RelSci Relationships

397

Number of Boards

1

Birthday

1972

Age

46

Relationships
RelSci Relationships are individuals Charles McDermott likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Impact Biomedicines, Inc.

Relationship likelihood: Strong

Co-Founder at Pulmatrix, Inc. (Inactive)

Relationship likelihood: Strong

Chief Scientific Officer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Average

President, Chief Executive Officer & Chairman of the Board at Kala Pharmaceuticals, Inc.

Relationship likelihood: Average

Chief Medical Officer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Average

Chief Accounting Officer, Chief Financial Officer & Treasurer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Average

Chief Financial Officer at Impact Biomedicines, Inc.

Relationship likelihood: Average

Professional at Medicxi Ventures (Jersey) Ltd.

Relationship likelihood: Average

Co-Founder & Partner at Medicxi Ventures (Jersey) Ltd.

Relationship likelihood: Average

Chief Operating Officer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Average

Paths to Charles McDermott
Potential Connections via
Relationship Science
You
Charles McDermott
President, Director & Chief Business Officer at Impact Biomedicines, Inc.
Education

The University of San Diego (USD) is a private Roman Catholic university in San Diego, California. The university offers 40 baccalaureate degrees, and several degrees in law, nursing, (masters, PhD, and DNP),and other doctorate programs. The university comprises seven different academic colleges.

The University of California, Santa Cruz, has earned international distinction as a university with high-impact research and an uncommon commitment to teaching and public service. A campus with world-class facilities and one of the most visually spectacular settings in higher education, UC Santa Cruz provides unparalleled opportunities for students to learn through hands-on experience. A commitment to environmental stewardship and community engagement are also central to UCSC's core values.

The University of California, Santa Barbara (commonly referred to as UC Santa Barbara or UCSB) is a public research university and one of the 10 general campuses of the University of California system. The main campus is located on a 1,022-acre (414 ha) site near Goleta, California, United States, 8 miles (13 km) from Santa Barbara and 100 miles (160 km) northwest of Los Angeles. Tracing its roots back to 1891 as an independent teachers' college, UCSB joined the University of California system in 1944 and is the third-oldest general-education campus in the system. UCSB traces its origins back to the Anna Blake School which was founded in 1891 and offered training in home economics and industrial arts. The Anna Blake School was taken over by the state in 1909 and became the Santa Barbara State Normal School. Intense lobbying by an interest group in the City of Santa Barbara, led by Thomas Storke and Pearl Chase, persuaded the State Legislature, Governor Earl Warren, and the Regents of the University of California to move the State College over to the more research-oriented University of California system in 1944. The State College system sued to stop the takeover, but the Governor did not support the suit. A state initiative was passed, however, to stop subsequent conversions of State Colleges to University of California campuses. From 1944 to 1958 the school was known as Santa Barbara College of the University of California, before taking on its current name. When the vacated Marine Corps training station in Goleta was purchased for the rapidly-growing college, Santa Barbara City College moved into the vacated State College buildings.

Career History
President, Director & Chief Business Officer
Current

Impact Biomedicines, Inc. engages in the development of cancer treatments. It engages in the development of fedratinib, a potent and selective oral molecule JAK2 kinase inhibitor for the treatment of myelofibrosis and polycythemia vera. The company was founded by John Hood, Catriona Jamieson and Raghu Saripalli in 2016 and is headquartered in San Diego, CA.

Co-President & Chief Business Officer
2013 - 2017

Kala Pharmaceuticals, Inc. is a biopharmaceutical company, focused on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Waltham, MA.

Vice President-Business Development, Eye Care & Drug Delivery
Prior

Allergan, Inc. operates as a global healthcare company. It engages in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company operates through two business segments: Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a broad range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, retinal diseases, and ocular surface disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, and eyelashes; and over-the-counter skin care products and urologic products. The Medical Devices segment produces a broad range of medical devices, including breast implants for augmentation, revision, and reconstructive surgery; obesity intervention products, including the Lap-Band System and the Orbera Intragastric Balloon System and facial aesthetics products. Its products are sold to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, and medical practitioners. The company was founded by Gavin S. Herbert in 1950 and is headquartered in Irvine, CA.

Boards & Committees
President, Director & Chief Business Officer
Current

Impact Biomedicines, Inc. engages in the development of cancer treatments. It engages in the development of fedratinib, a potent and selective oral molecule JAK2 kinase inhibitor for the treatment of myelofibrosis and polycythemia vera. The company was founded by John Hood, Catriona Jamieson and Raghu Saripalli in 2016 and is headquartered in San Diego, CA.

Transactions
Details Hidden

Kala Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Kala Pharmaceuticals, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Charles McDermott. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Charles McDermott's profile does not indicate a business or promotional relationship of any kind between RelSci and Charles McDermott.